Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Altimmune, Inc. (ALT) Class Action Lawsuit (May 2024)

Closed

8:24cv1315 • May 6, 2024

Class Period Start

December 1, 2023

Class Period End

April 26, 2024

PSLRA Deadline

July 5, 2024

Case Allegations

10b5

Statutes of Repose

Dec 1, 2026

Country

United States

Court

Federal Court

Docket History

Dec 16, 2024

Voluntary Dismissal

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Oct 2, 2024

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jul 1, 2024

Additional Complaint

Another plaintiff has filed a complaint on behalf of investors in Altimmune, Inc.. The allegations and class definitions are substantively the same.

May 6, 2024

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Altimmune, Inc..

TOP